Comparing Antibody-Drug Conjugates for Metastatic Breast Cancer
Results favor Enhertu for treating metastatic breast cancer that recurs or does not respond to first-line treatment.
Thanks to Lifesaving Cancer Research18,000,000cancer survivors in the United States are living with, through, and beyond their disease.
Your donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now